Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Viridian Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 177 | 171 | −6 |
| Shares | 91.4M | 94.6M | +3.19M (+3.5%) |
| Value | $1.23B | $1.32B | +$90.3M (+7.3%) |
New holders (22)
Institutions that held Viridian Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (28)
Institutions that held Viridian Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.